SciELO - Scientific Electronic Library Online

 
vol.84 issue4Proposed algorithm to recover anti-tuberculosis drugs that cause drug reaction with eosinophilia and systemic symptoms (DRESS)Adaptability of technology to address the learning gaps generated by the COVID-19 pandemic author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Anales de la Facultad de Medicina

Print version ISSN 1025-5583

An. Fac. med. vol.84 no.4 Lima Oct./Dec. 2023  Epub Dec 30, 2023

http://dx.doi.org/10.15381/anales.v84i4.26689 

Carta al Editor

Scientific production of trachoma worldwide: a bibliometric analysis during the period 1886 to 2022

Producción científica de tracoma a nivel mundial: un análisis bibliométrico durante el periodo 1886 a 2022

Christian Renzo Aquino-Canchari1  , Médico Cirujano
http://orcid.org/0000-0002-7718-5598

Sarai Gloria Chavez-Bustamante2  , Estudiante de Medicina Humana
http://orcid.org/0000-0002-8268-9424

Milie Lizet Zarate-Chavez3  , Estudiante de Medicina Humana
http://orcid.org/0009-0005-6730-4388

1 Universidad Peruana Los Andes. Huancayo, Perú.

2 Sociedad Científica Médico Estudiantil Continental (SOCIMEC), Universidad Continental. Huancayo, Perú.

3 Sociedad Científica de Estudiantes de Medicina los Andes (SOCIEMLA), Universidad Peruana Los Andes. Huancayo, Perú.

Dear Editor,

Trachoma is the leading infectious cause of preventable blindness worldwide 1. The Chlamydia trachomatis bacterium causes it and is characterized by inflammatory changes at the level of the conjunctiva in children with subsequent scarring, an opacity of the cornea, and blindness in adults. It is considered a public health problem in 42 countries (as of June 2022). It is endemic in the poorest, most disadvantaged, and rural areas of Africa, Central and South America, Asia, the Western Pacific, and the Middle East (2.

In 1996, the World Health Organization (WHO) spearheaded the Alliance for the Global Elimination of Trachoma by the Year 2020 (GET2020) in collaboration with member states, non-governmental organizations, academic institutions, and Pfizer Inc 3. This alliance supports implementing the SAFE (Surgery, Antibiotics, Facial Cleansing, and Environmental Improvement) intervention. In addition, the strengthening of national capacity regarding epidemiological studies, monitoring, surveillance, evaluation of projects, and the mobilization of resources 4.

Trachoma programs have achieved significant success around the world. However, while 15 countries that were previously endemic have now declared control, about twice as many have not. Especially now that the targets have been redefined in the WHO roadmap targeting the trachoma’s elimination and other neglected tropical diseases by 2030 5.

Figure 1. Number of documents by year on trachoma in the Scopus database (1892-2022). GET2020: Alliance for the Global Elimination of Trachoma by the Year 2020. 

Research is undoubtedly an indispensable tool for answering a wide range of questions about trachoma. In this context, we conducted a bibliometric study using the Scopus database. The search strategy was TITLE-ABS-KEY (Trachoma OR trachome OR tracoma OR trachomatis) AND (EXCLUDE (PUBYEAR, 2023)) AND (LIMIT-TO (PUBSTAGE, “final”)) AND (LIMIT-TO (SRCTYPE, “j”)). The following indicators were included: year of publication, type of article, authors with the largest number of articles, journals, affiliation, funding entity, countries, and access type. The search was conducted on October 4, 2023.

A total of 27 877 manuscripts were found, obtaining an average publication/year of 203.48. An irregular increase has been observed in scientific production on trachoma since the implementation of the GET 2020, with 2021 being the year with the highest number of documents published (n=880) (Figure 1).

The country, author, and journal with the highest scientific production were the United States (n = 8636), Schachter J (n = 311), and Sexually Transmitted Diseases (n = 1070); respectively. The most frequent type of manuscript was the original article (n = 21 867). National Institute of Allergy and Infectious Diseases was the institution with the highest number of funded studies (n = 2105) (Table 1).

Table 1. Characteristics of the scientific production on Trachoma in the world, Scopus (1886-2022). 

Our study revealed a notable increase in publications in recent years, which aligns with findings reported by Maciel AMS et al.6, who found that scientific production on trachoma increased in the last decade in Brazil. Supporting this trend, a scientometric study focusing on neglected tropical diseases (NTDs) in the Journal of the Brazilian Society of Tropical Medicine indicated that the number of publications related to NTDs increased by 49.9% (2128/4268) between 2011 and 2021 7.

The United States had the highest number of contributions. A bibliometric analysis of trachoma studies in the Web of Science Core Collection (WoS) database revealed that American researchers were responsible for 2585 out of 6556 articles. Furthermore, it is evident that the journal Sexually Transmitted Diseases and the institution of the University of California in San Francisco were the ones that contributed the most publications in both Scopus and WoS 8.

Another important aspect is that most of the articles on trachoma were open access. This finding speaks to the growing trend of making research freely available to the public, which promotes greater dissemination of knowledge and accessibility to findings relevant to researchers, policy decisions, and stakeholders 9.

The visibility of scientific articles is crucial for researchers and for their institutions in which they provide services, as well as for funding entities. Although considerable progress has been made toward the global elimination of trachoma, the time frame for its eradication will be longer than initially thought. The overall program will need to consider whether the current strategy is appropriate, especially in settings with high prevalence and recurrence of trachoma.

This work concludes that scientific production on trachoma has increased steadily in the last twenty years; however, it is low compared to other eye conditions or other neglected tropical diseases.

REFERENCES

1. Renneker KK, Emerson PM, Hooper PJ, Ngondi JM. Forecasting the elimination of active trachoma: An empirical model. PLoS Negl Trop Dis. 2022;16(7): e0010563. DOI: 10.1371/journal.pntd.0010563. [ Links ]

2. Gambhir M, Pinsent A. Possible changes in the transmissibility of trachoma following MDA and transmission reduction: implications for the GET2020 goals. Parasit Vectors. 2015; 8:530. DOI: 10.1186/s13071015-1133-6. [ Links ]

3. Pickering H, Chernet A, Sata E, Zerihun M, Williams CA, Breuer J, et al. Genomics of Ocular Chlamydia trachomatis After 5 Years of SAFE Interventions for Trachomain Amhara, Ethiopia. JInfect Dis. 2022; 225(6):994-1004. DOI: 10.1093/infdis/jiaa615. [ Links ]

4. Bilchut AH, Burroughs HR, Oldenburg CE, Lietman TM. Trachoma Control: ¿A Glass Half Full? Am J Trop Med Hyg. 2023;108(2):237-238. DOI: 10.4269/ajtmh.22-0760. [ Links ]

5. Senyonjo L, Downs P, Schmidt E, Bailey R, Blanchet K. Lessons learned for surveillance strategies for trachoma elimination as a public health problem, from the evaluation of approaches utilised by Guinea worm and onchocerciasis programmes: A literature review. PLoS Negl Trop Dis. 2021;15(1): e0009082. DOI: 10.1371/journal.pntd.0009082. [ Links ]

6. Maciel A, Ramos A, Ferreira A, Almeida N, Gomes V, Gómez D, Pires R. Scientometric analysis of research on trachoma in Brazil, 2000-2020. Rev Saude Publica. 2022; 56:97. DOI: 10.11606/s15188787.2022056004144. [ Links ]

7. Ferreira A, Heukelbach J, Costa C, Souza E, Maciel A, Correia D, Ramos A. Scientometric review of research on Neglected Tropical Diseases: a 31-yearperspective from the Journal of the Brazilian Society of Tropical Medicine. Rev Soc Bras Med Trop. 2023; 56: e0403-2022. DOI: 10.1590/0037-8682-04032022. [ Links ]

8. Yilmaz M, Dindar Demiray EK. Global Trends in Trachoma. Black Sea Journal of Health Science. 2022;5(3):519-25. DOI: 10.19127/bshealthscience.1141391. [ Links ]

9. Day S, Rennie S, Luo D, Tucker JD. Open to the public: paywalls and the public rationale for open access medical research publishing. Res Involv Engagem. 2020; 6:8. DOI: 10.1186/s40900-0200182-y. [ Links ]

Funding: None.

Cited as: Aquino-Canchari C, Chavez-Bustamante S, Zarate-Chavez M. Scientific production of trachoma worldwide: a bibliometric analysis for the period 1886 to 2022. An Fac med.2023;84(4):488-491. DOI: DOI: https://doi.org/10.15381/anales.v84i4.26689.

Received: August 19, 2023; Accepted: September 19, 2023

Corresponding author: Christian Renzo Aquino Canchari christian.aquino.canchari@gmail.com

Conflict of interests:

None.

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution License